The distinction of Fellowship in SIDP (FIDP) recognizes outstanding SIDP members with significant and sustained contributions to infectious diseases and the mission of SIDP. Successful applicants demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy. Nominees complete an application and provide supporting documentation, which are reviewed and scored by the Recognition Awards Committee. Successful applicants must demonstrate excellence in the area of Contributions to SIDP and at least two of the following categories: practice, education, or scholarship.
Please consider nominating a colleague for this distinction, which is awarded at the SIDP Business Meeting and Lecture Series in the fall. Further information regarding the nomination and application process can be found here. |
2022 Recipients
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP Dr. Monica Mahoney is a clinical pharmacy specialist in infectious diseases at Beth Israel Deaconess Medical Center. She received her PharmD degree from MCPHS University and completed PGY1 and PGY2-ID training at Tufts Medical Center, all in Boston. For the past 13 years, she has worked as an ID pharmacist at BIDMC, first as an inpatient clinical coordinator and rounding with the ID consult services. Three years ago, she transitioned to the ambulatory space, working in the outpatient ID and OPAT clinics. Here she found her passion, stating that “OPAT is my jam.” Through various publications, podcasts, presentations, and social media channels, she helps draw visibility to the multidisciplinary practice of OPAT. Dr. Mahoney is involved in a number of national pharmacy and ID organizations, including ACCP, ASHP, IDSA, SHEA, and SIDP. She is also currently serving as the President of the Massachusetts Society of Health-System Pharmacists. Dr. Mahoney has over 40 peer-reviewed publications, serves on the editorial advisory boards of ASHE, Annals of Pharmacotherapy, and Contagion, and most recently became an Associate Editor at OFID. You can follow her on Twitter via the handle @mmPharmD. |